Skip to main content

Table 1 Baseline characteristics of children enrolled in antimalarial in vivo efficacy study, Faladje, Mali.

From: Artemisinin-based combinations versus amodiaquine plus sulphadoxine-pyrimethamine for the treatment of uncomplicated malaria in Faladje, Mali

Characteristics AS+AQ N = 133 AS+SP N = 132 AQ+SP N = 132
Mean age ± S.D. (months) 34.49 ± 15.97 36.08 ± 15.97 37.56 ± 16.07
Range 6–59 6–59 8–59
Male gender, n (%) 72 (54.1) 64 (48.8) 82(62.1)
Mean weight ± SD (kg) 12.76 ± 3.30 12.77 ± 3.42 13.21 ± 3.49
Range 6.30–23.70 6–19.6 7.70–21.7
Mean height ± SD (cm) 92.05 ± 12.88 92.86 ± 14.18 94.39 ± 14.12
Range 63–115 64–120 65–133
Mean axillary temperature ± SD(°C) 38.59 ± .77 38.52 ± .78 38.58 ± .76
Range 37.5–40.2 37.5–40.6 37.5–40.8
Palpable spleen, n (%) 38(28.6) 40(30.3) 49 (37.1)
Mean haemoglobin ± SD (g/dl) 9.83 ± 1.80 9.71 ± 1.67 9.98 ± 1.59
Haemoglobin < 11 g/dl, n (%) 93(69.9) 102(77.3) 97(73.5)
GMPD/μl 24,113.4 22,846.8 24,051.7
Prior antimalarial use, n (%) 11(8.3) 4(3) 7(5.3)
Disease duration <= 1 day, n (%) 83(62.4) 92(69.7) 80(60.6)
Gametocyte carriage n (%) 1(0.8) 8 (6.1) 1(0.8)
  1. AS+AQ, artesunate + amodiaquine; AS+SP, artesunate + sulphadoxine-pyrimethamine;
  2. AQ+SP, amodiaquine + sulphadoxine-pyrimethamine. S.D, Standard deviation:
  3. G/dl: Grams per deciliter
  4. GMPD/μl: Geometric Mean Parasite Density per microliter.
  5. P-values (not shown) were calculated from 2 × 3 X2 test, (for categorical variables) and by KruskalWallis test (for continuous variables with non-normal distributions). Groups were not statistically different, except for gametocyte carriage (p = 0.006).